首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese
【2h】

Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese

机译:基于聚合酶链反应的C4AQ0和C4BQ0基因分型:与西南汉族系统性红斑狼疮的关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Methods: C4 null genes were determined by a polymerase chain reaction (PCR) procedure with sequence specific primers (PCR-SSP). The 2 bp insertion in exon 29, which was previously identified in non-Chinese populations and caused defective C4A genes, was directly typed by sequencing the whole exon 29 using exon specific primers. The exon 6 of complement C2 was also sequenced in both the patients and controls. >Results: The frequency of homozygous C4AQ0 allele was 12.5% (17/136) in patients with SLE compared with 1.1% (2/174) in controls (p<0.001, odds ratio (OR)=12.286, 95% confidence interval (95% CI) 2.786 to 54.170). There was no significant difference for homozygous C4BQ0 allele between patients with SLE and controls (p=0.699). Patients with the C4AQ0 gene had an increased risk of acquiring renal disorder, serositis, and anti-dsDNA antibodies compared with those without C4AQ0 (for renal disorder, p=0.018, OR=8.951, 95% CI 1.132 to 70.804; for serositis, p=0.011, OR 4.891, 95% CI 1.574 to 15.198; for anti-dsDNA, p=0.004, OR 7.630, 95%CI 1.636 to 35.584). None of the patients or controls had the 2 bp insertion in exon 29 of the C4 gene. The type I C2 deficiency was not detected in the 310 samples. >Conclusion: It is suggested that deficiency of C4A (not due to a 2 bp insertion in exon 29), but not C4B or C2, may be a risk factor for acquiring SLE in south west Han Chinese; this results in increased risk of renal disorder, serositis, and anti-dsDNA antibodies in patients with SLE. Racial differences seem to be relevant in susceptibility to SLE
机译:>方法:通过具有序列特异性引物(PCR-SSP)的聚合酶链反应(PCR)程序确定C4无效基因。通过使用外显子特异性引物对整个外显子29进行测序,可以直接确定外显子29中2 bp的插入片段,该序列先前已在非中国人群中发现并导致C4A基因缺陷。补体C2的外显子6也在患者和对照中都进行了测序。 >结果:SLE患者中纯合C4AQ0等位基因频率为12.5%(17/136),而对照组为1.1%(2/174)(p <0.001,优势比(OR)= 12.286 ,95%置信区间(95%CI)2.786至54.170)。 SLE患者和对照组之间的纯合C4BQ0等位基因没有显着差异(p = 0.699)。与没有C4AQ0的患者相比,具有C4AQ0基因的患者罹患肾脏疾病,浆膜炎和抗dsDNA抗体的风险增加(对于肾脏疾病,p = 0.018,OR = 8.951,95%CI 1.132至70.804;对于浆膜炎,p = 0.011,或4.891,95%CI 1.574至15.198;对于抗dsDNA,p = 0.004,或7.630,95%CI 1.636至35.584)。没有患者或对照在C4基因的外显子29上插入2 bp。在310个样本中未检测到I C2型缺陷。 >结论:建议在西南汉族人群中,缺乏C4A(不是由于外显子29插入2 bp)引起的,但不是C4B或C2缺乏,可能是导致SLE的危险因素。这会导致SLE患者发生肾脏疾病,浆膜炎和抗dsDNA抗体的风险增加。种族差异似乎与SLE易感性有关

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号